Antigens, circulating in the blood during malarial infections, have been impiicated in immune protection, immunosuppression, and immune-complex formation. We used a monoclonal antibody (MAb 7H8) to identify an antigen (Ag-7H8) in the sera of mice infected with Plasmodium yoelii. The major form of the antigen has a molecular weight of -120,000 in P. yoelii, with minor components of 220,000; 65,000 to 75,000; and 45,000. Ag-7H8 remains antigenic after boiling for 5 min. A two-sited assay was developed with MAb 7H8 that demonstrated that the Ag-7H8 has at least two similar epitopes per molecule. The two-sited assay was used to follow Ag-7H8 in the blood of mice during lethal (strain 17XL) and nonlethal (strain 17XNL) P. yoelii infections. Ag-7H8 appeared on days 6 and 7 after infection with 106 and 104 17XL P. yoelii parasites, respectively, and remained until the animals died. It was in plasma samples between days 6 and 14 after 17XNL P. yoelii injections in several inbred strains of mice, regardless of the course of parasitemia. Thus, the kinetics of antigenemia correspond with early stages of infection and not with the number of circulating parasites.
The presence and importance of circulating antigens similar to those in P. falciparum infections have not been studied extensively for rodent malarias. In this study we identify and characterize an antigen of Plasmodium yoelii that has several characteristics of S antigens (i.e., presence in sera and thermostability). Using a monoclonal antibody (MAb) to this antigen, we developed a two-sited assay for detecting it in the sera of infected mice and then followed the kinetics of antigenemia during lethal and nonlethal P. yoelii infections. Results showed that the antigen is present during the initial stages of infection regardless of the course of parasitemia.
Strains of mice and parasites. In the majority of the studies, 6-to 8-week-old BALB/c mice (Cumberland View Farms, Clinton, Tenn.) were injected intraperitoneally (i.p.) with specified numbers of either the 17XL (lethal) or 17XNL (nonlethal) strain of P. yoelii. Parasitemias were monitored every other day from Giemsa-stained tail blood smears. In studies comparing the kinetics of parasitemia and antigenemia, mice of the following strains were injected i.p. with 106 17XNL P. yoelii parasites: AKR/J (Jackson Laboratory, Bar Harbor, Maine), C57BL/6Boy and C57BL/6 (H-2k) (NIAID breeding contract; Bioqual Inc., Rockville, Md.). Parasites used in indirect immunofluorescence (IIF) studies included Plasmodium berghei (NYU/2) and P. falciparum (Malayan Camp strain) from Aotus monkeys.
Production of MAbs. Details of the procedures for the production of anti-P. yoelii MAbs have been described previously (11) . The hybridoma reported here was produced by infecting BALB/c mice with 104 17 XL P. yoelii parasites. When the parasitemias reached -54% 9 days later, mice were killed, and a suspension of spleen cells was prepared and fused with the P3-X63-NS/1 cell line. Hybrids were selected in a hypoxanthine-aminopterin-thymidine medium and screened by IIF with acetone-fixed smears of P. yoelii (14) and by radioimmunoassay as previously described (12) with extracts of 17XL and 17XNL parasites. The hybrid cell line (7H8) used in this study was press). Extracts of 17XL P. yoelii, prepared by freeze-thawing Percoll-enriched, P. yoelii-infected erythrocytes, were incubated for 10 min at 37°C in 5% SDS-5% 2-mercaptoethanol and then electrophoresed on a 5 to 15% SDS-PAG according to Laemmli (6) . Proteins were transblotted onto nitrocellulose paper (13) Bur- lington, Vt.).
The assay was initially developed with extracts of P. yoelii parasites. During preparation of the extracts, blood samples from BALB/c mice with high 17XL P. yoelii parasitemias were fractionated on a Percoll gradient to enrich for parasitized erythrocytes. Parasitized cells were freeze-thawed three times and centrifuged at 10,000 x g for 30 min. The supernatant, designated as a water-soluble cell cytosol, was removed, and the remaining pellet was washed twice with saline and extracted with 1% Triton X-100. The supernatant, containing proteins released from the erythrocyte and parasite membranes, and the Triton-X-100-insoluble pellet, containing erythrocyte and parasite cytoskeletons, were saved. The protein concentrations of the three extracts were determined by a protein determining reagent (Bio-Rad).
In assays using boiled extracts or plasma, samples were placed in a rapidly boiling water bath for 5 min. The aggregated proteins were centrifuged at 1,000 x g for 10 negative. However, a characteristic set of fluorescent spots can be seen in trophozoite-and schizont-containing erythrocytes ( Fig. 1C through F) . The fluorescent spots appear to be external to the parasitophorous vacuole membrane but internal to the erythrocyte membrane. Occasionally, the erythrocyte membrane ruptured during preparation of the smear, and discrete spots of fluorescence can be seen as released intact granules. Similar patterns of fluorescence were produced in erythrocytes infected with P. berghei and P. falciparum ( Fig. 1E and F, respectively) . In addition to fluorescence spots that appeared outside the parasite, there was strong fluorescence from the 17XNL P. yoelii and P. falciparum parasites (trophozoites and schizonts) themselves ( Fig. 1D and F) . In contrast, 17XL P. yoelii and P. berghei parasites were negative or only marginally positive ( Fig. 1C and E ). IIF studies with intact erythrocytes and mechanically released intact parasites demonstrated that the antigen is not expressed on these membrane surfaces.
Biochemical studies. Immune precipitation studies with
[35S]methionine-labeled parasites were conducted to determine the molecular weight of the antigen bound by MAb 7H8 (Fig. 2) . Under nonreducing conditions, the antigen appeared as a doublet or triplet at -120, 135, and 148 kilodaltons (kDa) (large arrows), with several lesser bands between 65,000 and 75,000 (small arrows). Similar results were obtained by Western blot analysis under reducing conditions (Fig. 2) . A predominant protein band of -117,000 to 120,000 (large arrows) was present with lesser bands at molecular weights of 200,000 and 45,000 (small arrows). MAb 7H8 also identified a protein in P. berghei with the significantly lower molecular weight of -90,000.
Development of a two-sited assay for detecting Ag-7H8.
Initially, a direct-binding assay was used to titrate the preparation of alkaline-phosphatase-labeled MAb 7H8 and to determine if the antigen was water soluble. In this assay, microtiter wells were treated with 100 ,u of approximately 1 mg of P. yoelii antigen extracts of either parasite cytosol, Triton-X-100-extracted membrane proteins, or Triton-X-100-insoluble cytoskeletons per ml. The results demonstrated that the labeled antigen bound preferentially to an antigen in the parasite cytosol (Fig. 3) . In later studies, the conjugate was used routinely at a 1:500 dilution. Next, a two-sited assay was attempted. In step 1 of this initial assay, wells were coated with 100 RI of partially purified MAb 7H8 at a 1-mg/ml concentration or with 3%
BSA. Extracts of P. yoelii or plasma samples from acutely infected mice were used as the source of the antigen in step 2, and a 1:500 dilution of alkaline-phosphatase-labeled MAb 7H8 was employed in step 3. The P. yoelii antigen was usually captured by MAb-coated wells but not by wells coated with BSA (Fig. 4, upper left portion) . However, when large amounts of Ag-7H8 were used (e.g., as in parasite extract 2), a substantial amount of reactivity was observed in BSA-coated wells. Thus, in the presence of high antigen concentrations, both captured and nonspecifically bound antigens were detected. These results demonstrated that P.
yoelii cytosol contains an antigen with at least two similar epitopes and that the antigen appears in acute-phase plasma. Aliquots from four parasite extracts and plasma samples from mice acutely infected with 17XL and 17XNL P. yoelii were heated in a boiling water bath for 5 min to determine if the antigen detected in the two-sited assay is heat stable. Paired samples of unboiled extract or plasma and the colorless supernatant from boiled samples were compared. Ag-7H8 could easily be detected after boiling (Fig. 4, lower  half) . However, the amount of reactivity was frequently diminished after boiling the samples, especially the sera. Finally, we determined the optimal amount of partially purified MAb to apply to the plate (step 1 of the assay). Accordingly, wells were coated with various amounts of MAb 7H8 (Fig. 5) . When wells were coated with less than 10 ,ug/ml (i.e., 1 ,ug per well), they were unable to capture sufficient amounts of the antigen. Thus, in all subsequent experiments wells were coated with 100 ,ug of MAb 7H8 per ml.
In the development of the assay, ascites from two different clones of MAb 7H8 were used. Similar results were obtained for kinetics of reactivity and titration curves.
Detection of Ag-7H8 in plasma collected during P. yoelii infection. Plasma samples collected during the 17XL P. yoelii infection in BALB/c mice were diluted 1:1 in 3% BSA in PBS and assayed for Ag-7H8. The results demonstrated that the antigen could be detected in plasma on days 6 and 7 after injection of 104 and 106 parasites, respectively (Fig. 6) .
Various inbred strains of mice were infected with 106 0. Fig. 7) . The appearance of Ag-7H8 in plasma correlated with the onset and early stages of infection and did not parallel the course of parasitemia. DISCUSSION In this study we identified an antigen (7H8) that circulates in the peripheral blood during the early stages of P. yoelii infection. This antigen is produced by the parasite and has a major high-molecular-weight component of -117,000 to 120,000 as determined by both immune precipitation of [35S]methionine-labeled proteins and by Western blot analysis. In addition to the major band detected by the two assays, several lesser bands can be identified, including bands of 200,000; 65,000 to 75,000; and 45,000. Thus, it appears that the epitope is on molecules of diverse sizes. The identification of the same epitope on molecules of different sizes is not unusual. For example, the dominant protein on the surface of malarial merozoites in P. yoelii has a major band of 230,000 plus lesser bands of 197,000, 160,000, 151,000, 126,000, 90,000, 56,000, and 28,000 (4). MAb 8B11 (Fig. 2 Determination of the optimal amount of partially purified MAb 7H8 to apply to microtiter wells. In step 1 microtiter wells were coated with various amounts from 1 to 1,000 ,ug of partially purified MAb 7H8 per ml. PBS, normal mouse serum (NMS), acute-phase plasma samples from mice with -30% parasitemia, and P. yoelii cytosol extract (Ag) (-1 mg/ml) were diluted 1:1 with 3% BSA in PBS and used in step 2. A 1:500 dilution of alkalinephosphatase-labeled MAb 7H8 was used in step 3. Results are expressed as means ± 1 standard deviation for triplicate samples. and acute-phase plasma samples after boiling for 5 min (Fig.  4) . However, the amount of activity is reduced after boiling, especially when plasma samples from acutely infected mice are used. The reason for diminished activity is not clear but could be due to: (i) a portion of Ag-7H8 becoming trapped in the protein aggregate formed during boiling (which is considerably greater in plasma than in extracts); (ii) some of the molecules (i.e., bands) that possess epitope 7H8 being thermostable, whereas others are not; or (iii) the basic structure of the molecule being altered by heating but the epitope recognized by MAb 7H8 being only moderately affected. The last possibility could result in a lowered-affinity interaction between the MAb and the epitope. We are now attempting to make this distinction by identifying the protein moieties in plasma samples after boiling. However, the data shown in Fig. 4 support the conclusion that Ag-7H8 in parasite extracts and a portion of the antigen in plasma samples are stable to boiling for 5 min.
Should Ag-7H8 be classified as an S antigen? Currently, there appear to be several heat-stable antigens in the sera of P. falciparum-infected individuals, but only one of these antigens fits the complete definition for S antigens. This INFECT. IMMUN. antigen is in the plasma of infected individuals, produces a band in double-diffusion Ouchterlony analysis against a set of well-characterized immune sera, maintains antigenicity as determined by Ouchterlony analysis after boiling the antigen for 5 min, and has antigenic diversity among isolates (1-3) . Recently, the amino acid sequence of the S antigen from two isolates has been determined (2, 3). Accordingly, it will be Detection of Ag-7H8 in the plasma samples of various strains of mice infected with the 17XNL strain of P. yoelii. Groups of nine mice each were infected with 106 17XNL P. yoelii parasites. Parasitemias (the left axis and ascending curves) are the mean for six to nine animals. Blood samples, collected from three mice on the necessary to determine the sequence of Ag-7H8 and to compare it with the above S antigen before we can be certain if it is a true S antigen. Theoretically, Ag-7H8 could be the S antigen described above, as Ag-7H8 is in P. falciparum ( Fig.  1 ) as well as in P. yoelii, but it is more likely that Ag-7H8 is an antigen that has yet to be described.
Ag-7H8 appeared in plasma samples 6 to 7 days after infection ( Fig. 6 and 7) , regardless of the inoculation dose in both lethal and nonlethal P. yoelii infections. At that time, the antigens detected were probably in the free state and not in immune complexes, as only low levels of antibodies were being produced (data not shown). As the infection progressed, Ag-7H8 was detected up to day 14. It is possible that during this time antibodies were produced against it, resulting in the clearance of the antigen from the circulation. The kinetics of antigenemia were similar in BALB/c, AKR, and C57BL/6 mice, although the courses of parasitemia differed greatly in these inbred strains (Fig. 7) . Thus, the kinetics of antigenemia correlate with the initial stages of infection and not the level of parasitemia.
The above explanation of the clearance of Ag-7H8 is based on the assumption that antibodies are produced against it during the early stages of infection. This, however, may not be true. In the last several years we have infected mice with the 17XL and 17XNL strains of P. yoelii, removed their spleens at various times after infection, and used these tissues for hybridoma production. Only 1 (7H8) of -200 MAbs produces the pattern of fluorescence described here, suggesting that Ag-7H8 might be a weak immunogen. In addition, careful examination of SDS-PAG results (Fig. 2 Is Ag-7H8 secreted into sera, released during erythrocyte rupture and parasite reinvasion, or produced by degenerating parasites? The pattern of fluorescence produced by MAb 7H8 is consistent with that of a secreted protein and appears similar to that reported for the S antigen of P. falciparum (2, 9) . Ag-7H8 is absent in ring stage parasites and appears during early trophozoite formation (Fig. 1) . The antigen appears to be located primarily in the space external to the parasite and internal to the erythrocyte membrane. The finding that the antigen remains in discrete granules when the erythrocyte membrane is ruptured but when the parasite membrane remains intact supports the idea that the antigen is transported packaged in vesicles through the erythrocyte and then either stored within the erythrocyte cytoplasm or actively secreted into the serum. Attempts to make this distinction have not been successful.
Circulating antigens in sera could have a role in immunosuppression, immune protection, and immune-complex formation. Recently, Saul et al. (10; Saul et al., in press) showed that a MAb against P. falcipartum S antigens could block parasite growth in vitro. The mechanism of this MAb is unclear. Accordingly, Ag-7H8 could play several immunologic roles. The results from 17XNL P. yoelii studies suggest that Ag-7H8 may be involved in immune protection or immune-complex formation (Fig. 7) . Studies are in progress to elucidate the role of this antigen.
A two-sited assay was developed for detecting Ag-7H8. The sensitivity of the assay was difficult to ascertain, but antigens could be detected circulating in the blood when the parasitemias were <2% (Fig. 7) . Technical difficulties encountered with the two-sited assay for detecting Ag-7H8 were minimal. However, as the amount of Ag-7H8 in extracts of malarial parasites increased, the amount of color development in wells not coated with MAb 7H8 (i.e., the BSA used in step 1) increased. This suggests that during the overnight incubation period, some of the antigens bound directly to the plate. It appears that in samples containing large amounts of Ag-7H8, both captured and nonspecifically bound antigens were detected. In addition, it is possible that Ag-7H8 was not detected beyond day 14 because antibodies produced by the host interfered with the assay.
Since Ag-7H8 is in P. yoelii, P. berghei, and P. falciparum parasites, it is likely that this assay has general application for the detection of this circulating malarial antigen. Preliminary studies show that Ag-7H8 can be detected in plasma samples of individuals living in The Gambia and Nigeria with acute P. falciparum infections.
Thus, identification of a P. yoelii antigen that shares many characteristics with S antigens in P. falciparum may provide us with an animal model system for determining if this family of high-molecular-weight, water-soluble, heat-stable antigens found in sera during acute malaria plays a role in immune protection, immunosuppression, or immune complex formation.
